Impaired Glucose Tolerance in Recipients of Encapsulated Islet Grafts Is Caused by Slow Absorption of Intraperitoneal Insulin by Strubbe, J., et al.
EI.SEVIER 
PII  S0963-6897(96)00168-6 
Cell Transplantation,  Vol. 5, No. 5S-2, pp. 51-56,  1996 
Copyright © 1996 Elsevier Science Inc. 
Printed in the USA. All rights reserved 
0963-6897/96  $15.00 + .00 
Encapsulation and Immunoisolation Technologies 
Category 7 
7.01  IMPAIRED GLUCOSE  TOLERANCE IN RECIPIENTS OF ENCAPSULATED 
ISLET GRAFTS IS CAUSED BY SLOW ABSORPTION  OF 
INTRAPERITONEAL  INSULIN 
De Vos P,  De Haan BJ,  Vegter D,  Strubbe J,  Van Schilfgaarde 
R. Groningen, The Netherlands. 
As  a  consequence  of its  volume,  a  microencapsulated 
islet graft can only be implanted  into the peritoneal cavity. 
Rat  recipients  of succesfull  alglnate-PLL  microencapsulated  islet 
~lografts were subjected  to intravenous (IVGTT) and oral gluco- 
se  tolerance  tests  (OGTT) 4  to  6  weeks after  implantation and 
were found to be glucose intolerant,  and there was no increase  of 
plasma insulin levels.  This impaired glucose tolerance may very 
well  be the consequence of the fact  that microencapsulated islets 
remain  freely  floating  in  the  peritoneal  cavity  without vascular 
access which implies that  insnlm is not directly  absorbed into the 
circulation,  like with vascularized  islets, but has to be transferred 
from  the  peritoneal  fluid  to  the  bloodstream.  To  investigate 
whether die transplantation  site as such contributes to the interfe- 
rence  widl optimal transport kinetics  between the islets and blood 
we  infused  insulin  into  the  peritoneal  cavity  of conscious and 
freely  moving rats to mimic the gradual  release  of insulin from 
an  encapsulated  islet  graft.  We  observed  virtually  no  rise  of 
insulin  levels  and  it  took  30  minutes  until  glucose  levels  had 
dropped significantly,  with infusion of 20 pM/nfin insulin during 
15 ntht (the amount of insulin produced by a  native rat pancreas 
ill  response to  OGTT).  With  higher insulin doses,  there  was a 
dose  dependent  rise  of insulin  and  decrease  of glucose  levels. 
When  compared  to  intraportal  infusions with  the  same  insulin 
dosages,  however,  tbey  were  strongly  delayed  and  reduced  as 
well  as  prolonged.  This  strongly delayed  effect  of peritoneally 
infused insulin on both plasma insulin levels and glucose levels 
explains,  the lack  of elevation  of insulin levels  and file disturbed 
~vlUCoSC tolerance  ill  recipients  of  ml  encapsulated  islet  graft. 
ith  view on the  clinical  efficacy  of file  bioartificial  pancreas, 
our findings indicate  that  we should focus on finding  or creating 
a transplantation site  which, more than the uantodified peritol~al 
cavity,  permits for close contact  between the bloodstreanl and the 
encapsulated  islet  tissue. 
7.02  SUCCESSFUL  XENOGRAFT  IN 
STREPTOZOTOCIN  INDUCED DIABETIC RAT 
USING DISPERSED  HUMSTER  ISLET TISSUE 
WITHIN MICROPOROUS  POLYPROPYLENE 
BAG 
Imai M, Kawabata N, Kato K, Kawabara T, Nakazawa F, 
Sawa M, Kasai S, Mitu M; Asahikawa JAPAN 
The nonendocrine components may provide paracrine 
factors that actually promote development of new islets form 
pancreatic ductal epithelium inislet tissue transplantation. We 
propose that impure islet preparations, referred to as dispersed 
pancreatic islet tissue (DPIT), minimize islet loss and may 
engraft better than purified islets. We developed an innovative 
bag type of biohybrid artificial  pancrease utilizing microporous 
polypropylene membrane. This membrane is 25 tim thickness 
andhas 0.075 ×  0.25  ttmpores.  Mieroporous polypropylane 
bag (MPPB), but is not permiated by immunoglobulin G or 
iymphocytes. In this study, we used this bag containning 
humster DPIT for biohybrid artificial  pancrease to 
sterptozotocine indused diabetic rat.  In vitro glucose-insulin 
kinetics test revialed that MPPB containing DPIT could 
respond rapidly to an increase in glucose consentoration. In 
vivo xenotransplantation study, serum glucose levels in all of 
the recipient rats decreased to euglycemia at least I month. 
Some recipient reverted to diabetes after MPPB removal on day 
30. Application of the innovative device of MPPB containing 
DPIT improve the survival and the function of humster islets 
even after xenotransplantation significantly. 